History is littered with ideas to control male fertility – and men are keen to have them. But with the heyday of the contraceptive industry apparently past, bringing the two together requires great determination and inventiveness, Andy Extance finds.
Treatments for rare diseases challenge a system more used to blockbuster drugs.
Drug approvals are evolving - but some say not fast enough.
It’s supposedly getting easier for innovative drugs for rare diseases to reach the market. So why, asks Andy Extance, is hesitancy still proving devastating to desperate families?